Optometrists in San Lorenzo, PR Accepting Medicare
9 Optometrists found. Showing 1 - 9
 Safety Lens & Eye Wear Optometrist Medicare: Not Enrolled in Medicare Practice Location: 216 Calle Munoz Rivera S, Suite 3, San Lorenzo, PR 00754 Phone: 787-736-2465 Fax: 787-736-2465 |
 Dr. Carlos Reoyo, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12 B San Lorenzo Shopping Center, Better Vision Optica, San Lorenzo, PR 00754 Phone: 787-715-3744 Fax: 787-715-3745 |
Dr. Elvin B Pena, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 216 Calle Munoz Rivera S, Plaza Buxo 3, San Lorenzo, PR 00754 Phone: 787-736-2465 Fax: 787-736-1565 |
Osvaldo Carriles Optometrist Medicare: Medicare Enrolled Practice Location: St Munoz Rivera #157, San Lorenzo, PR 00754 Phone: 787-736-6649 Fax: 787-715-6649 |
 Annette A Montalvo-nadal, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: Tous Soto 150 Esquina Valeriano Munoz, San Lorenzo, PR 00754 Phone: 787-448-6010 Fax: 787-736-2465 |
Better Vision Optometrist Medicare: Not Enrolled in Medicare Practice Location: San Lorenzo Shopping Ctr, Suite 12 B Carr 183 Km 1 1, San Lorenzo, PR 00754 Phone: 787-715-3744 Fax: 787-715-3745 |
San Lorenzo Vision Center Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 150 Calle Tous Soto S, San Lorenzo, PR 00754 Phone: 787-736-2465 Fax: 787-736-2465 |
Dr. Nilda Vazquez, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12 B San Lorenzo Shopping Center, Better Vision Optica, San Lorenzo, PR 00754 Phone: 787-715-3744 Fax: 787-715-3745 |
Optometry World Optometrist Medicare: Not Enrolled in Medicare Practice Location: St Munoz Rivera 157, San Lorenzo, PR 00754 Phone: 787-736-6649 Fax: 787-715-6649 |
News Archive
Migration trends of SSA-educated physicians to America have increased over the last decade
A dramatic rise in the number of physicians trained in Sub-Saharan Africa (SSA) emigrating to the United States has resulted in a "brain drain" explored in the dissertation of Vanderbilt student Akhenaten Tankwanchi, a portion of which was published recently in PLOS Medicine.
PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that Japan's Pharmaceuticals and Medical Devices Agency has approved LYNPARZA tablets for use in patients with unresectable or recurrent BRCA-mutated, human epidermal growth factor receptor 2 -negative breast cancer who have received prior chemotherapy.
LLNL scientists issued patent for producing antimicrobial compounds to fight superbugs
Superbugs, antibiotic-resistant bacteria, have been on the rise since antibiotics were first introduced 80 years ago. That's because these germ-fighting agents have lost their punch from being overprescribed and misused, allowing bacteria pathogens to develop immunities against them.
Swedish Orphan Biovitrum, Biogen Idec announce data of rFVIIIFc Phase 1/2a trial for hemophilia A
Biogen Idec and Swedish Orphan Biovitrum today announced Phase 1/2a trial data showing that the companies' long-lasting fully-recombinant factor VIII Fc fusion protein (rFVIIIFc) was well tolerated and demonstrated an approximately 1.7-fold increase in half-life compared with Advate, a commercially-available factor VIII product, in 16 previously-treated patients with severe hemophilia A.
› Verified 2 days ago
Optometrists
Speech-Language Pathologists
Chiropractors
Physical Therapists
Occupational Therapists